Nisen Perry
SEC CIK 1683791 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Dir | 119.8K | — | — | 5 | 2022-06-14 | 2026-06-05 |
Most active insiders at TEVA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Francis Richard D | Pres, CEO | — | $31.26M |
| 2 | MIGNONE ROBERTO | Dir | — | $22.82M |
| 3 | Kalif Eliyahu Sharon | EVP, CFO | — | $20.72M |
| 4 | Sabag Mark | See "Remarks" | — | $13.15M |
| 5 | Daniell Richard | EVP, European Commercial | — | $12.08M |
| 6 | Hughes Eric A | See "Remarks" | — | $4.17M |
| 7 | Fox Christine | EVP, U.S. Commercial | — | $2.75M |
| 8 | Lippman Evan | EVP, Business Development | — | $2.16M |
| 9 | Weiss Amir | CAO | — | $1.41M |
| 10 | Shields Matthew | EVP, Gbl Ops | — | $1.40M |
| 17 | Nisen Perry | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-08 16:04 | 2026-06-05 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Nisen Perry | Dir | M - OptEx | — | +14.5K | 119.8K | +14% | — |
| D | 2025-06-09 | 2025-06-06 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Nisen Perry | Dir | M - OptEx | — | +9,632 | 105.3K | +10% | — |
| D | 2024-06-17 | 2024-06-15 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Nisen Perry | Dir | M - OptEx | — | +21.1K | 95.7K | +28% | — |
| D | 2023-08-07 | 2023-08-04 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Nisen Perry | Dir | M - OptEx | — | +15.8K | 74.6K | +27% | — |
| D | 2022-06-16 | 2022-06-14 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Nisen Perry | Dir | M - OptEx | — | +14.5K | 58.8K | +33% | — |
Purchase Sale Sale after option exercise All abbreviations